Glycemic Control Following GLP-1 RA or Basal Insulin Initiation in Real-World Practice: A Retrospective, Observational, Longitudinal Cohort Study.
Xuejun Victor PengRory J McCrimmonLeah ShepherdAnders BossRobert LubwamaTerry DexNeil SkolnikLinong JiAngelo AvogaroLawrence BlondePublished in: Diabetes therapy : research, treatment and education of diabetes and related disorders (2020)
For adults with T2D inadequately controlled on OADs, this analysis reveals an unmet clinical need. Initiation of first injectable therapy did not occur until HbA1c was considerably above target, when control is harder to achieve. Results suggest that in individuals with baseline HbA1c ≥ 9.0%, only a minority are likely to achieve an HbA1c < 7% with a GLP-1 RA or BI alone.
Keyphrases
- glycemic control
- type diabetes
- rheumatoid arthritis
- blood glucose
- disease activity
- weight loss
- cross sectional
- primary care
- healthcare
- insulin resistance
- ankylosing spondylitis
- interstitial lung disease
- systemic lupus erythematosus
- quality improvement
- adipose tissue
- mesenchymal stem cells
- tissue engineering
- idiopathic pulmonary fibrosis